Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 36% ± 21% | |
GABAergic neuron | 5 studies | 40% ± 18% | |
interneuron | 4 studies | 33% ± 21% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 35% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 98% | 1187.38 | 167 / 170 | 16% | 2.61 | 72 / 459 |
ovary | 96% | 212.18 | 173 / 180 | 7% | 0.37 | 32 / 430 |
brain | 78% | 143.19 | 2060 / 2642 | 24% | 0.71 | 168 / 705 |
bladder | 86% | 145.62 | 18 / 21 | 8% | 0.35 | 39 / 504 |
kidney | 85% | 121.00 | 76 / 89 | 1% | 0.02 | 12 / 901 |
intestine | 71% | 44.37 | 687 / 966 | 8% | 0.21 | 44 / 527 |
adrenal gland | 20% | 19.59 | 52 / 258 | 59% | 5.50 | 135 / 230 |
esophagus | 62% | 187.20 | 892 / 1445 | 7% | 0.20 | 13 / 183 |
muscle | 68% | 56.21 | 544 / 803 | 0% | 0 | 0 / 0 |
breast | 28% | 17.32 | 127 / 459 | 29% | 1.32 | 329 / 1118 |
heart | 56% | 35.06 | 479 / 861 | 0% | 0 | 0 / 0 |
prostate | 36% | 23.89 | 89 / 245 | 4% | 0.05 | 18 / 502 |
blood vessel | 32% | 29.37 | 429 / 1335 | 0% | 0 | 0 / 0 |
lung | 11% | 5.10 | 61 / 578 | 3% | 0.29 | 38 / 1155 |
skin | 8% | 2.93 | 148 / 1809 | 2% | 0.08 | 11 / 472 |
stomach | 3% | 0.98 | 12 / 359 | 7% | 0.21 | 20 / 286 |
pancreas | 7% | 2.47 | 24 / 328 | 1% | 0.05 | 2 / 178 |
adipose | 7% | 3.56 | 84 / 1204 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.13 | 3 / 653 | 1% | 0.01 | 4 / 605 |
liver | 0% | 0.43 | 1 / 226 | 0% | 0.01 | 2 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003184 | Biological process | pulmonary valve morphogenesis |
GO_0003186 | Biological process | tricuspid valve morphogenesis |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0030199 | Biological process | collagen fibril organization |
GO_0003180 | Biological process | aortic valve morphogenesis |
GO_0006508 | Biological process | proteolysis |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0003183 | Biological process | mitral valve morphogenesis |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ADAMTS19 |
Protein name | ADAM metallopeptidase with thrombospondin type 1 motif 19 A disintegrin and metalloproteinase with thrombospondin motifs 19 (ADAM-TS 19) (ADAM-TS19) (ADAMTS-19) (EC 3.4.24.-) |
Synonyms | |
Description | |
Accessions | H0Y8Y0 ENST00000505791.5 D6R9M2 A0A1X7SBR9 ENST00000274487.9 Q8TE59 ENST00000502709.1 |